Validation of the model medication adherence questionnaire to measure the adherence to oral medication among patients with type 2 diabetes mellitus in Sri Lanka
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20231669Keywords:
Diabetes, Sensitivity, Specificity, Compliance, Likelihood ratio testAbstract
Background: The model medication adherence questionnaire (MMA) measures oral medication adherence among patients with type 2 diabetes (DM). The validity of the questionnaire needs to be objectively demonstrated.
Methods: A descriptive cross-sectional study was carried out among adult patients with type 2 DM who attended clinics in District General Hospital (DGH) Gampaha. A sample of 150 patients was recruited consecutively to establish the criterion and construct validity. The criterion was the composite index of pill count, recital dosage and regular clinic attendance. Sensitivity and specificity with 95% confidence-intervals (CI) were established. Construct validity: convergent and discriminative, was assessed. Results were analyzed by Spearmen correlation and Man-Whitney-U test with p values.
Results: The accuracy of the test was denoted by the area under the curve which is 0.87 (95% CI 0.81–0.93) with p<0.0001. The best cut-off point was 70. Patients who score >70 have good adherence to the medication while ≤70 have average adherence. This has a sensitivity of 92.9% (95% CI 85.5–96.9%), a specificity of 72.5% (95% CI 58–83.7%) with a misclassification rate of 14%. The positive likelihood ratio (LR) is 10.2. High positive LR (>10) represents that adherence is very likely in a person with a score >70. The negative likelihood ratio is 0.3 and is in the intermediate range. It suggests that a score <70 is suggestive but insufficient to rule out the non-adherence. The ideal cutoff to predict the optimum HbA1C of MMA is 67.
Conclusions: MMA is a valid questionnaire to measure medication adherence.
Metrics
References
Garfield S, Clifford S, Eliasson L, Barber N, Willson a. Suitability of measures of self-reported medication adherence for routine clinical use: A systematic review. BMC Med Res Methodol. 2011;11(1):149.
Sabate E. Adherence to Long-Term Therapies: Evidence for Action. 1st ed. World Health Organization. 2003;12-4.
Powers MA, Bardsley JK, Cypress M. Diabetes Self-management Education and Support in Adults with Type 2 Diabetes: A Consensus Report of the American Diabetes Association, the Association of Diabetes Care and Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association. J Am Assoc Nurse Pract. 2021;33(12):1314-31.
Standard G, Clifford, Perez-Nieves M, Skalicky AM, Reaney M. In search of the Gold Standard for compliance measurement. Arch Intern Med. 1979;39(6):627-8.
Al-Qazaz HK, Sulaiman SA, Hassali MA, Shafie AA, Sundram S, Al-Nuri R SF. Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. Int J Clin Pharm. 2011;33(6):1028-35.
Gonzalez JS, Schneider HE, Wexler DJ, Psaros C, Delahanty LM, Cagliero E, et al. Validity of medication adherence self-reports in adults with type 2 diabetes. Diabetes Care. 2013;36(4):831-7.
Johnson SB. Methodological Issues in Diabetes Research. Diabetes Care. 1992;15(11):1658-67.
Kenna LA, Labbé L, Barrett JS, Pfister M. Modeling and simulation of adherence: Approaches and applications in therapeutics. AAPS J. 2006;7(2):E390-407.
Kleppe JLJH, Cees. The development of the ProMAS: a Probabilistic Medication Adherence Scale. Patient Prefer Adherence. 2015;9:355-67.
Sajatovic, Martha, Velligan D, Weiden PJ, Valenstein GO. Measurement of Psychiatric Treatment Adherence. Psychosom Res. 2012;29(6):997-1003.
Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37(2):113-24.
Williams AB, Amico R, Bova C. A proposal for quality standards for measuring medication adherence in research. AIDS Behav. 2013;17(1):284-97.
van den Boogaard J, Lyimo RA, Boeree MJ, Kibiki GS, Aarnoutse RE. Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study. Bull World Health Organ. 2011;89(9):632-9.
Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074-90.
Svarstad BL, Chewning B, Sleath BL, Claesson C. The brief medication questionnaire: A tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37:113-24.
Gonzalez JS, Schneider HE. Methodological issues in the assessment of diabetes treatment adherence. Curr Diab Rep. 2011;11:472-9.
Sriwarakorn S, Krittiyanunt S, Sakulbumrungsil R. Sensitivity and Specificity of Thai-Version Brief Medication Questionnaire. J Health Res. 2010;24(3):129-34.
Christian J, Beck CK, Hays RD. A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors. Ann Intern Med. 2013;134(10):968.
Mann DM, Ponieman D, Leventhal H, Halm E. Predictors of adherence to diabetes medications: The role of disease and medication beliefs. J Behav Med. 2009;32:278-84.
Wijesinghe MSD. Selected Aspects of Quality of Care Received by Diabetes Mellitus Patients Attending and Medical Clinics at National Hospital Sri Lanka. Post Graduate Institute of Medicine. 2007.
Thenuwara NVJ. Quality of Care, Quality of Life and Cost Implications for Patients with Diabetes Mellitus Attending Outpatient Clinics at State Hospitals of Western Province. MD Community Medicine. Post Graduate Institute of Medicine. 2013.
Perera S, Abeysena C. Levels & Associated Factors of Adherence to Oral Medication, Validation of a Model to Predict Adherence and an Intervention to Improve Adherence among Patients with Type 2 Diabetes Mellitus Attending Colombo North Teaching Hospital. Uniersity of Colombo. 2019.
Gunathilake G, D. Kottahachchi SS. The drug compliance among patients with diabetes in Sri Lankan setting. Sri Lanka J Diabetes Endocrinol Metab. 2017;91(1):399-404.
Hajian-Tilaki K. Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation. Caspian J Intern Med. 2013;4(2):627-35.
Naing L, Winn T, Rusli BN. Practical Issues in Calculating the Sample Size for Prevalence Studies. Available at: https://www.scribd.com/doc/63105077/ How-to-Calculate-Sample-Size. Accessed on 14 March 2023.
Arambewela MH, Somasundaram N, Fernando KRAS, Jayasena PM, Chandrasekara CMPH, Kusumsiri DP, et al. Standards of care in managing patients with type 2 diabetes in an outpatient clinic in tertiary care center in Sri Lanka. Sri Lanka J Diabetes Endocrinol Metab. 2018;8(01):23-31.
Lau DT, Nau DP. Oral Antihyperglycemic Medication Nonadherence and Subsequent Hospitalization Among Individuals With Type 2 Diabetes. Diabetes Care. 2004;27(9):2149-53.
Lam WY, Fresco P. Medication Adherence Measures: An Overview. Biomed Res Int. 2015;1-12.
Ranasinghe P, Jayawardena R, Katulanda P, Constantine GR, Ramanayake V. Translation and Validation of the Sinhalese Version of the Brief Medication Questionnaire in Patients with Diabetes Mellitus. J Diabetes Res. 2018;2018:1-7.
Ghazanfari Z, Haghdoost AA, Alizadeh SM, Atapour FZ. A Comparison of HbA1c and Fasting Blood Sugar Tests in General Population. Int J Prev Med. 2010;1(3):187-94.
Kilpatrick ES. Haemoglobin A1cin the diagnosis and monitoring of diabetes mellitus. J Clin Pathol. 2008;61(9):977-82.
Feldman BS, Cohen-Stavi CJ, Leibowitz M. Defining the Role of Medication Adherence in Poor Glycemic Control among a General Adult Population with Diabetes. PLoS One. 2014;9(9):e108145.
Hajian-Tilaki K. Sample size estimation in diagnostic test studies of biomedical informatics. J Biomed Inform. 2014;48:193-204.
Deeks JJ, Altman DG. Statistics Notes: Diagnostic tests 4: likelihood ratios. Br Med J. 2004;329(7458):168.
Mohd, A.M, Phung H, Sun J, Morisky DE. The predictors to medication adherence among adults with diabetes in the United Arab Emirates. J Diabetes Metab Disord. 2016;15(1):1-9.
Rwegerera GM. Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania– A cross-sectional study. Pan Afr Med J. 2014;17:252.
Rwegerera GM, Moshomo T, Gaenamong M. Antidiabetic medication adherence and associated factors among patients in Botswana; implications for the future. 2018;15(1):1-9.
Saiguay W, Sakthong P. The psychometric testing of the Thai version of the health utilities index in patients with ischemic heart disease. Quality of Life Research. 2013;22(7):1753-9.
Matza LS, Park J, Coyne KS, Skinner EP, Malley KG, Wolever RQ. Derivation and validation of the ASK-12 adherence barrier survey. Ann Pharmacotherap. 2009;43:1621-30.
Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1-24.
Sakthong, Phantipa RC. Psychometric Properties of the Thai Version of the 8-item Morisky Medication Adherence Scale in Patients with Type 2 Diabetes. Ann Pharmacother. 2009;43(5):950-7.
Lee WY, Ahn J, Kim JH. Reliability and validity of a self-reported measure of medication adherence in patients with type 2 diabetes mellitus in Korea. J Int Med Res. 2013;41:1098-110.
Schmidt FL, Hunter JE, Urry VW. Statistical power in criterion-related validation studies. J Appl Psychol. 1976;61(4):473-85.
Downloads
Published
How to Cite
Issue
Section
